BETAAccess all features while we're in beta! Some features may become paid later.Got feedback? Reach us 👉

Loading GTBP charts…

Search ticker or company⌘K

GTBP

01Multicharts 02Comparables 03Price target

May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy

GTBP · GT Biopharma, Inc. fundamentals · vpside

vpside

⌘K

GTBPMarket cap $218M/Last filing 10-Q · 14 Aug 2026/GTBPMarket cap $218M/Last filing 10-Q · 14 Aug 2026/GTBPMarket cap $218M/Last filing 10-Q · 14 Aug 2026/GTBPMarket cap $218M/Last filing 10-Q · 14 Aug 2026/

Filings synced 13:22 · Prices: prior close 29 Oct

GTBP

GT Biopharma, Inc.

Nasdaq · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

01Multicharts 02Comparables 03Price target

Add a metric37 metrics

Revenue, quarterly

$1$0

vpside.com

Q4 ’16Q1 ’18Q2 ’19Q2 ’20Q3 ’21

Company filings · 10-Q filed 10 Nov 2021 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

100.0%+83.8 pp year on year

200%0%−200%−400%

vpside.com

Q2 ’11Q3 ’12Q4 ’13Q4 ’14Q1 ’16

Company filings · 10-Q/A filed 28 Feb 2018 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$5M−5.1% year on year

$10M$5M$0

vpside.com

Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26

Company filings · 10-Q filed 14 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$4M

$5M$0−$5M−$10M−$15M

vpside.com

Q4 ’17Q2 ’18Q4 ’18Q2 ’19Q4 ’19

Company filings · 10-K filed 16 Apr 2021 · TTM = last four quartersvpside.com

Chart 05 is empty

Chart 06 is empty

Fundamentals: company filings · Q4 = full year − nine months · TTM = last four quarters